Clinical Trial: A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444385) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects' on Feb. 26.

Brief Summary: A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 Under Fed Conditions in Healthy Adult Male Subjects

Study Start Date: Feb. 26

Study Type: INTERVENTIONAL

Condition: Benign Prostatic Hyperplasia

Intervention: DRUG: AD-116, AD-1161

Single-dose oral administration of AD-116 or AD-1161, according to randomized sequence.

Recruitment Status: RECRUITING

Sponsor: Addpharma Inc.

Disclaimer: Curated by HT Syndication....